Search

5 results for “Pague Menos (PGMN3)

ANVISA Revokes Ban, Clearing Path for Mercado Livre, iFood to Enter Brazil’s $4 Billion Digital Pharmacy Market
PROTechAug 11

ANVISA Revokes Ban, Clearing Path for Mercado Livre, iFood to Enter Brazil’s $4 Billion Digital Pharmacy Market

Brazil's health regulator ANVISA revoked measures blocking medicine sales on marketplaces, opening a R$20 billion e-commerce front.

Pague Menos Posts Record 6.5% EBITDA Margin for Q2 2026, But Financial Costs and SSS Slowdown Temper Net Income Growth
InvestingAug 04

Pague Menos Posts Record 6.5% EBITDA Margin for Q2 2026, But Financial Costs and SSS Slowdown Temper Net Income Growth

Brazilian pharmacy chain Pague Menos (PGMN3) hit a record operational margin in 2Q26, though rising financial expenses and slower same-store sales growth limited net income.

Pague Menos Posts Record 6.5% EBITDA Margin Despite Sales Miss, Driven by Efficiency Gains
PROMarketsAug 04

Pague Menos Posts Record 6.5% EBITDA Margin Despite Sales Miss, Driven by Efficiency Gains

Brazilian pharmacy chain Pague Menos (PGMN3) achieved a record 6.5% adj. EBITDA margin in Q2 2026, defying a 9.3% sales miss.

Pague Menos Posts Record 6.5% EBITDA Margin and Cuts Financial Leverage to 1.8x in Q2 2026
MarketsAug 04

Pague Menos Posts Record 6.5% EBITDA Margin and Cuts Financial Leverage to 1.8x in Q2 2026

Pague Menos (PGMN3) reported a record 6.5% Adjusted EBITDA margin, driving net income up 22.2% in Q2, while leverage dropped for the 12th consecutive quarter.

Pague Menos Posts Record 6.5% EBITDA Margin on Extrafarma Synergies, Surpasses R$1 Billion in Digital Sales
Small CapsAug 04

Pague Menos Posts Record 6.5% EBITDA Margin on Extrafarma Synergies, Surpasses R$1 Billion in Digital Sales

Brazilian pharmaceutical retailer Pague Menos (PGMN3) reports strong 2Q26 earnings, driven by integration success and digital growth.